immunotherapy

A new algorithm detects when immunotherapies create surges of T cell responses in melanoma patients.

Learn how immunotherapy is revolutionizing autoimmune disorder treatment.

In this webinar, Daryl Cole will highlight how new technologies improve antibody discovery and production.

A new study finds an unexpected role for hepatocytes in anticancer immunity.

The FOXO1 transcription factor boosts T cells’ memory and reduces dysfunction.

Cancer vaccines offer the opportunity to use the patient’s own immune system in the fight against tumors.

From smart receptors to novel biologics, scientists plan to overcome the challenges of treating solid tumors.

Discover what researchers have learned about varying immunotherapy response rates between patients with the same cancer types.

Natural killer (NK) cells target infected and oncogenic cells, but are difficult to work with in vitro. Discover novel approaches to producing genetically modified NK cells for cell therapy. 

Filippo Rossignoli discusses the challenges he faced when employing lentiviruses to produce immunotherapies and how he overcame these obstacles.

An expert panel will discuss the interplay between cancer and the immune system, and how researchers develop immunotherapies and other immune-supporting strategies against cancer. 

Discover tips for guiding drug development from discovery to the clinic.

Hundreds of bispecific antibodies are in development for imaging, diagnostic, and therapeutic applications against diseases such as cancer. 

Oncolytic viruses can help glioblastoma respond to immunotherapy.

Scientists present the latest research on immune cell responses to cancer, the role of epigenetics in cancer, and molecular imaging of the tumor microenvironment.

Learn about the tumor microenvironment (TME), a key influencer of cancer growth, spread, and treatment success.

New research may make immunotherapy possible for hard-to-treat brain tumors.

A therapy for type 1 diabetes is the first to treat patients before symptoms appear, paving the way toward preventing this and other autoimmune diseases.

Scientists isolate rare yet desirable CAR T cell subtypes using an innovative cell sorter system within a closed manufacturing process.